Danaher Corporation vs Wix.Com Ltd — how do they compare? Danaher Corporation trades at $204.28 (market cap $145.83B), while Wix.Com Ltd trades at $65.97 (market cap $2.79B). The key difference: Danaher Corporation is far larger — about 52.3× Wix.Com Ltd's market cap, and Danaher Corporation pays a 0.77% dividend while Wix.Com Ltd pays none. Which is the better fit depends on your goals.
| DHR | WIX | |
|---|---|---|
Market Cap | $145.83B | $2.79B |
Sector | Health | Technology |
52-Week High | $242.05 | $184.24 |
52-Week Low | $161.91 | $40.43 |
Enterprise Value | $168.04B | $3.87B |
Dividend Yield | 0.77% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $209.26, up 2.2% today, with strong technical momentum as the price sits above key support levels. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.92. Fundamentals show robust profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst sentiment is overwhelmingly positive with 69% buy ratings and a $202.33 consensus price target. Recent news highlights the acquisition of Masimo and new product launches in its biotechnology segment.
The outlook for DHR remains favorable driven by earnings beats and strategic acquisitions, but investors face risks from elevated valuation multiples and potential macroeconomic headwinds. The stock's current technical overbought condition suggests near-term consolidation may occur, yet long-term growth prospects in life sciences support a bullish stance. Key watch points include Q3 2026 earnings results and integration progress of recent acquisitions.
Wix trades at $62.43, up 3.7% today, with a bullish technical signal and strong analyst consensus. Recent earnings show mixed results, beating estimates in three of the last four quarters, while revenue grew to $1.99B in 2025. The stock faces headwinds from a class action lawsuit following a Q1 2026 miss and a 27% price drop in May 2026.
The outlook is cautiously optimistic given Wall Street's $79.75 price target and 66% buy ratings, but litigation over financial disclosures and negative shareholder equity pose significant risks. Revenue growth remains a key catalyst, though profitability volatility requires monitoring.
Trailing returns across standard periods
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →